DK8-10959-81247
3 vaccinations
8 coded responses
26 check-ins
8 free-text entries
7 call cases
- Sex
- Male
- Age at first dose
- 31-35
- ZIP prefix
- 921 / CA
- Registered
- 2020-12-31
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-25
Dose 1 — Pfizer-BioNTech
-
2020-12-31
Registered in v-safe
- 2021-01-01
- 2021-01-10
-
2021-01-12
Dose 2 — Pfizer-BioNTech
- 2021-01-12
-
2021-01-13
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Chills, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-13
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities1 call case(s)
-
2021-01-14
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Muscle or body aches, Fatigue or tiredness, Diarrhea · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-01-14
Report sent to call center — days 1–6 daily, dose 2Be unable to work · Be unable to do your normal daily activities1 call case(s)
-
2021-01-15
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-01-16
- 2021-01-17
- 2021-01-19
- 2021-01-26
- 2021-02-04
- 2021-02-09
-
2021-02-16
Survey response — day 35, dose 2MedDRA: Dyspnoea, Headache, Tachycardia — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: Tachycardia, sob, headacheMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-16
Report sent to call center — day 35, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-02-23
Survey response — day 42, dose 2MedDRA: Specialist consultation, Tachycardia — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Symptoms: Tachycardia with minimal exertion · Healthcare visit (other): Cardiologist referralMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-23
Report sent to call center — day 42, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-04-13
Survey response — 3 months, dose 2MedDRA: Medical counselling, Postural orthostatic tachycardia syndrome, Tachycardia — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: I have been seeing a cardiologist for tachycardia workup. He thinks it is POTS but waiting for final testing to rule put other causes. These symptoms came on about 3 weeks after the vaccine and have been occurring since then.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-13
Report sent to call center — 3 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-06-10
- 2021-07-01
-
2021-07-13
Survey response — 6 months, dose 2MedDRA: Dyspnoea, Office visit, Palpitations, Tachycardia — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Symptoms: Palpitations, tachycardia, SOB · Healthcare visit (other): Cardiology follow upMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-07-13
Report sent to call center — 6 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-07-21
-
2021-10-06
Dose 3 — Pfizer-BioNTech
- 2021-10-07
- 2021-10-08
- 2021-10-09
- 2021-10-11
- 2021-10-12
- 2021-10-15
-
2021-10-27
Survey response — day 21, dose 3MedDRA: Palpitations, Tachycardia — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Return of palpitations and tachycardia.MedDRA releases: 2024-11 · check-in free text available
-
2021-11-03
Survey response — day 28, dose 3MedDRA: Unevaluable event — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Same as last check inMedDRA releases: 2024-11 · check-in free text available
-
2021-11-17
Survey response — day 42, dose 3MedDRA: Exercise tolerance decreased, Heart rate increased — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Increased heart rate with postural changes. Decreased exercise tolerance.MedDRA releases: 2024-11 · check-in free text available
-
2022-01-07
Survey response — 3 months, dose 3MedDRA: Exercise tolerance decreased, Tachycardia — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Tachycardia, decreased exercise toleranceMedDRA releases: 2024-11 · check-in free text available
-
2022-01-07
Report sent to call center — 3 months, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-01-17
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-25 | Pfizer-BioNTech | |
| 2 | 2021-01-12 | Pfizer-BioNTech | |
| 3 | 2021-10-06 | Pfizer-BioNTech | No |
Call center
7 call center cases
7 unsuccessful
Free text
Release 4 — day 35, dose 2
Symptoms: Tachycardia, sob, headache
Release 4 — day 42, dose 2
Symptoms: Tachycardia with minimal exertion
Healthcare visit (other): Cardiologist referral
Release 7 — 3 months, dose 2
Symptoms: I have been seeing a cardiologist for tachycardia workup. He thinks it is POTS but waiting for final testing to rule put other causes. These symptoms came on about 3 weeks after the vaccine and have been occurring since then.
Release 9 — 6 months, dose 2
Release 10 — day 21, dose 3
Symptoms: Return of palpitations and tachycardia.
Release 10 — day 28, dose 3
Symptoms: Same as last check in
Release 10 — day 42, dose 3
Symptoms: Increased heart rate with postural changes. Decreased exercise tolerance.
Release 10 — 3 months, dose 3
Symptoms: Tachycardia, decreased exercise tolerance
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | ✓ | ✓ | ✓ |
| HCVO | Specialist consultation | ✓ | ✓ | ✓ |
| SD | Dyspnoea | ✓ | ✓ | ✓ |
| SD | Exercise tolerance decreased | · | · | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Heart rate increased | · | · | ✓ |
| SD | Medical counselling | ✓ | ✓ | ✓ |
| SD | Palpitations | ✓ | ✓ | ✓ |
| SD | Postural orthostatic tachycardia syndrome | ✓ | ✓ | ✓ |
| SD | Tachycardia | ✓ | ✓ | ✓ |
| SD | Unevaluable event | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release